The Preoperative Prognostic Nutritional Index for the Prediction of Outcomes in Patients with Early-Stage Ovarian Clear Cell Carcinoma.
Nobuhisa YoshikawaKosuke YoshidaSatoshi TamauchiYoshiki IkedaKimihiro NishinoKaoru NiimiShiro SuzukiFumitaka KikkawaHiroaki KajiyamaPublished in: Scientific reports (2020)
The prognostic nutritional index (PNI), which reflects preoperative malnutrition, is useful for predicting the incidence of postoperative complications and has been reported in recent years to predict the long-term prognosis of various malignancies. The purpose of this study was to clarify the significance of PNI as a prognostic factor for early-stage clear cell ovarian carcinoma. A total of 82 patients with stage I-II (FIGO 2014) ovarian clear cell carcinoma undergoing primary surgery at our hospital from January 2005 to December 2017 were enrolled. PNI was calculated using the formula: 10 × serum albumin (g/ dL) + 0.005 × peripheral blood lymphocyte count (/mm3). Preoperative PNI exhibited relatively high area under the curve value (0.709) for 5 year survival, and the optimal cutoff value was 46.5. The overall survival was significantly shorter in the PNI-low group than in the PNI-high group. Multivariate analysis showed that high PNI was a significant independent prognostic factor for favorable prognosis (hazard ratio = 0.102, p = 0.010). There was no significant difference in recurrence-free survival between the two groups (p = 0.220), but the postrecurrence survival was significantly longer in the PNI-high group than in the PNI-low group (p = 0.0383). The preoperative PNI was a useful predictor of prognosis, even in early-stage ovarian clear cell carcinoma.
Keyphrases
- early stage
- free survival
- prognostic factors
- peripheral blood
- patients undergoing
- clear cell
- healthcare
- type diabetes
- acute coronary syndrome
- adipose tissue
- coronary artery disease
- preterm infants
- adverse drug
- data analysis
- coronary artery bypass
- preterm birth
- low birth weight
- insulin resistance
- human milk
- rectal cancer